Novel Clinical Biomarkers of Glaucoma Management

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1104985

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Glaucoma is a leading cause of irreversible blindness, and its management is hindered by the lack of effective clinical measures of the disease. This project seeks to develop new clinical tests to take the “guesswork” out of its management – measures that can correctly identify those at high-risk of progression, accurately determine treatment efficacy and sensitively detect disease progression, thus preventing the irreversible loss of vision from this disease.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2020

Funding Scheme: Early Career Fellowships

Funding Amount: $366,252.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Ophthalmology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | clinical test | disease progression | glaucoma | retinal ganglion cell

Related Links